Outcomes of Transcatheter Balloon Valvuloplasty for Mitral Valve

Abstract

Objective: To evaluate the effectiveness of transcatheter balloon valvuloplasty (TBV) in patients with mitral valve stenosis by assessing post-procedural expansion of the mitral valve area.

Materials and Methods: From March 2023 to March 2024, 16 patients diagnosed with mitral valve stenosis were evaluated at the International Cardiology Center. Among them, 15 patients underwent TBV. The study included patients aged 37 to 69 years with no prior history of TBV. The cohort comprised 11  females (68.75%) and 5 males (31.25%). Diabetes mellitus was present in 3 patients (18.75%).

Results: TBV was successfully performed in all 15 patients, achieving a 100% procedural success rate. The mitral valve area increased from 1.20 ± 0.4 cm² to 2.90 ± 0.9 cm² post-procedure. Sinus rhythm was restored in 6 of 7 patients undergoing cardioversion. No in-hospital mortality or major complications occurred within the 30-day follow-up period.

Conclusion: TBV is an effective minimally invasive alternative to surgical valve replacement, providing significant improvements in hemodynamic
parameters and clinical outcomes.